Addiction Prevention and Responsible Opioid Practices Act
Latest action · Jul 21, 2020 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJul 21, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Addiction Prevention and Responsible Opioid Practices Act
This bill addresses substance use and mental health related to opiods, including by imposing an excise tax on opioids; modifying controlled substances regulations, prescription drug monitoring programs (PDMPs), and health insurance coverage; and requiring other activities.
Specifically, the bill (1) establishes federal licensure requirements for pharmaceutical representatives who market opioids, (2) requires certain training and PDMP participation as conditions for controlled substance registration, and (3) withdraws regulatory approval for opioids with ultra-high doses.
In addition, as a condition for receiving certain grants, recipients must, for example, mandate the use of PDMPs in specified ways and increase data-sharing. Additionally, to meet certain certification standards, health information technology must be interoperable with PDMPs.
Additionally, the Centers for Medicare & Medicaid Services (CMS) must reimburse mental health services provided through telehealth under Medicare and develop a web-based tool to compare opioid prescribing in state Medicaid programs. The bill also creates grants to support compliance with requirements to provide parity in insurance coverage for mental health and substance use disorder services. The Government Accountability Office must study health care coverage and reimbursements for substance use disorder treatments.
Furthermore, the Department of Health and Human Services and the CMS must develop quality measures and guidelines for treatment of non-fatal overdoses, and the Department of Justice must operate a drug take-back program. The National Academies of Sciences, Engineering, and Medicine and medical and dental schools must also report on Medicare coverage of non-opioid treatment for back pain and educational courses on pain management and opioid prescribing practices, respectively.
Cosponsors 2
Members who signed on, in the order they did. All signed on Sep 1, 2020.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CT | Jahana Hayes | Sep 1, 2020 | |
| D-GU | Michael F. Q. San Nicolas | Sep 1, 2020 |
Committees 4
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Jul 21, 2020 |
| House | Judiciary Committee | Referred Jul 21, 2020 |
| House | Education and Workforce Committee | Referred Jul 21, 2020 |
| House | Ways and Means Committee | Referred Jul 21, 2020 |
| Health Subcommittee | Referred Jul 21, 2020 |
Actions 3
Everything that happened, newest first.
- Jul 21, 2020Introduced in House
- Jul 21, 2020Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Education and Labor, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jul 21, 2020Referred to the Subcommittee on Health.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 128, July 21, 2020, page H3612.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 4242 | Addiction Prevention and Responsible Opioid Practices Act | Related bill | Jul 21, 2020 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To establish programs related to prevention of prescription opioid misuse, and for other purposes.
- Short Title(s) as Introduced
- Addiction Prevention and Responsible Opioid Practices Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Alternative treatments
- Business ethics
- Business records
- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Emergency medical services and trauma care
- Government information and archives
- Government studies and investigations
- Health
- Health care costs and insurance
- Health care coverage and access
- Health care quality
- Health information and medical records
- Health personnel
- Health programs administration and funding
- Health promotion and preventive care
- Health technology, devices, supplies
- Hospital care
- Indian social and development programs
- Internet and video services
- Internet, web applications, social media
- Licensing and registrations
- Marketing and advertising
- Medicaid
- Medical education
- Medical ethics
- Medicare
- Mental health
- Military medicine
- Minority health
- Prescription drugs
- Sales and excise taxes
- State and local government operations
- User charges and fees
- Veterans' medical care
Text 1
Each version as it was printed, newest first.
- Jul 21, 2020Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
